Volume 70, Issue 10, Pages (November 2006)

Slides:



Advertisements
Similar presentations
Volume 63, Issue 2, Pages (February 2003)
Advertisements

E. Homsi, P. Janino, J.B.L. de Faria  Kidney International 
Increased expression of heparanase in overt diabetic nephropathy
Volume 79, Issue 1, Pages (January 2011)
Volume 59, Issue 5, Pages (May 2001)
Volume 76, Issue 7, Pages (October 2009)
Li-Wen Lai, Kim-Chong Yong, Yeong-Hau H. Lien  Kidney International 
Volume 84, Issue 3, Pages (September 2013)
Y.-H.H. Lien, K.-C. Yong, C. Cho, S. Igarashi, L.-W. Lai 
Volume 76, Issue 3, Pages (August 2009)
Volume 79, Issue 9, Pages (May 2011)
Volume 75, Issue 2, Pages (January 2009)
Volume 63, Issue 4, Pages (April 2003)
Hua Liu, Steven A. Bigler, Jeffrey R. Henegar, Radhakrishna Baliga 
Volume 79, Issue 1, Pages (January 2011)
Volume 73, Issue 4, Pages (February 2008)
Volume 70, Issue 7, Pages (October 2006)
Volume 69, Issue 1, Pages (January 2006)
Vikas Chander, PhD, Kanwaljit Chopra, PhD  Journal of Vascular Surgery 
Volume 63, Issue 2, Pages (February 2003)
High volume peritoneal dialysis vs daily hemodialysis: A randomized, controlled trial in patients with acute kidney injury  D.P. Gabriel, J.T. Caramori,
Karl A. Nath, Anthony J. Croatt, Jill J. Haggard, Joseph P. Grande 
Decreased renal ischemia–reperfusion injury by IL-16 inactivation
Gilbert R. Kinsey, Liping Huang, Amy L. Vergis, Li Li, Mark D. Okusa 
Down-regulation of Na+ transporters and AQP2 is responsible for acyclovir-induced polyuria and hypophosphatemia  Lúcia Andrade, Nancy A. Rebouças, Antonio.
Volume 70, Issue 11, Pages (December 2006)
Ischemic and non-ischemic acute kidney injury cause hepatic damage
Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury  Jianchun Chen, Jian-Kang.
Volume 73, Issue 12, Pages (June 2008)
Volume 63, Issue 2, Pages (February 2003)
Volume 85, Issue 1, Pages (January 2014)
Volume 70, Issue 12, Pages (December 2006)
Resistance to ischemic acute renal failure in the Brown Norway rat: A new model to study cytoprotection  David P. Basile, Deborah Donohoe, X.I.A. Cao,
Volume 56, Issue 2, Pages (August 1999)
Volume 56, Issue 3, Pages (September 1999)
Volume 73, Issue 5, Pages (March 2008)
Volume 63, Issue 5, Pages (May 2003)
Volume 55, Issue 6, Pages (June 1999)
Fructose intake as a risk factor for kidney stone disease
The third World Kidney Day: Looking back and thinking forward
Volume 72, Issue 8, Pages (October 2007)
Volume 74, Issue 5, Pages (September 2008)
Volume 79, Issue 2, Pages (January 2011)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 56, Issue 5, Pages (November 1999)
Role of the T-cell receptor in kidney ischemia–reperfusion injury
Volume 60, Issue 6, Pages (December 2001)
Volume 72, Issue 9, Pages (November 2007)
Volume 69, Issue 10, Pages (May 2006)
Volume 83, Issue 2, Pages (February 2013)
What can be learned using microarrays?
Volume 71, Issue 6, Pages (March 2007)
Florian E. Togel, Christof Westenfelder 
Apoptosis in ischemic renal injury: Roles of GTP depletion and p53
Volume 88, Issue 6, Pages (December 2015)
Organ transplantation goes to the movies
Volume 69, Issue 5, Pages (March 2006)
Volume 80, Issue 10, Pages (November 2011)
Volume 61, Issue 3, Pages (March 2002)
Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure  D.W. Johnson, B. Pat, D.A. Vesey, Z.
Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction  Malcolm F. Hand, William G. Haynes, David J.
Volume 70, Issue 3, Pages (August 2006)
Volume 70, Issue 3, Pages (August 2006)
Miguel G. Salom, Bárbara Bonacasa  Kidney International 
E. Homsi, P. Janino, J.B.L. de Faria  Kidney International 
Volume 74, Issue 8, Pages (October 2008)
A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia–reperfusion injury  L.-W. Lai, K.-C. Yong,
Volume 85, Issue 1, Pages (January 2014)
Volume 69, Issue 11, Pages (June 2006)
Presentation transcript:

Volume 70, Issue 10, Pages 1742-1749 (November 2006) The role of heme oxygenase 1 in rapamycin-induced renal dysfunction after ischemia and reperfusion injury  G.M. Gonçalves, M.A. Cenedeze, C.Q. Feitoza, P.M.H. Wang, A.P.F. Bertocchi, M.J. Damião, H.S. Pinheiro, V.P. Antunes Teixeira, M.A. dos Reis, A. Pacheco-Silva, N.O.S. Câmara  Kidney International  Volume 70, Issue 10, Pages 1742-1749 (November 2006) DOI: 10.1038/sj.ki.5001893 Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 1 Mean serum creatinine (s.d.) of animals subjected to IRI (N=9) or not (sham, N=5), pre-treated with rapamycin (days -1 and 0), daily treated (N=8) or not (N=12). (a) Ischemic and reperfusion injured animals pre-treated with rapamycin presented a sustained renal dysfunction, more prominent at 48 (*P<0.05) and 120h (*P<0.05), compared to IRI animals. Sham and rapamycin-treated sham animals had similar levels of serum creatinine. (b) Ischemic and reperfusion injured animals daily treated with rapamycin presented a sustained renal dysfunction, more prominent at 48 (*P<0.05) and 120h (*P<0.05), compared to IRI animals. Kidney International 2006 70, 1742-1749DOI: (10.1038/sj.ki.5001893) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 2 Morphometric analyses in animals subjected to IRI and treated or not with rapamycin. (a) Mean percentages of ATN (s.d) in animals subjected or not to IRI and pre-treated or not with rapamycin. (b) Mean percentages of tubular regeneration (s.d) in animals subjected or not to IRI and pre-treated or not with rapamycin (N=5–12). Morphometric analyses were performed in 25 random fields in the outer medulla and compared at two time points after reperfusion. Animals subjected to IRI and pre-treated with rapamycin presented higher levels of ATN at 24 and 120h (*P<0.05) and impaired regeneration at 120h (*P<0.05), compared to IRI animals. Kidney International 2006 70, 1742-1749DOI: (10.1038/sj.ki.5001893) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 3 HO-1 gene transcript analysis in normal animals and in those subjected or not to IRI and pre-treated or not with rapamycin (N=5–12). HO-1 mRNA was markedly upregulated after IRI; however, rapamycin pre-treatment induced an even higher expression, significantly at 48h after reperfusion (*P<0.05). Kidney International 2006 70, 1742-1749DOI: (10.1038/sj.ki.5001893) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 4 Renal function and HO-1 mRNA expression in animals treated with COPPIX before IRI. (a) Mean serum creatinine (s.d.) levels of animals subjected or not to IRI, pre-treated with rapamycin, COPPIX, both drugs or not (N=5–12). COPPIX significantly decreased renal dysfunction in animals just subjected to IRI (*vs IRI, P=0.011), and more strikingly, in those pre-treated with rapamycin (**vs rapamycin-treated animals subjected to IRI, P<0.01). Interestingly, at 120h after reperfusion, COPPIX normalized renal function in animals pre-treated with rapamycin and subjected to IRI (***vs rapamycin-treated animals subjected to IRI, P=0.004). (b) HO-1 mRNA expression after IRI. Rapamycin and COPPIX induced an increase in HO-1 mRNA after IRI; however, when the two drugs were administered together the effect was even higher (*vs IRI, P<0.05). This effect was less evident at 120h after surgery, but still significant (**vs IRI, P<0.05). Kidney International 2006 70, 1742-1749DOI: (10.1038/sj.ki.5001893) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 5 Renal function and HO-1 mRNA expression in animals subjected to IRI and treated with COPPIX at different time points. (a) Mean serum creatinine (s.d.) levels of animals subjected or not to IRI, pre-treated with rapamycin (days -1 and 0), and COPPIX (at different time points, -1, 0, or +1) (N=5–12). Animals were killed 24h after surgery (COPPIX at day -1) or after the COPPIX administration (day 0 and day +1). COPPIX significantly decreased renal dysfunction in animals just subjected to IRI, and in those pre-treated with rapamycin, only when administered at day -1. (b) HO-1 mRNA expression after IRI. Rapamycin and COPPIX induced an increase in HO-1 mRNA after IRI. This effect was still evident when COPPIX was administered late. Kidney International 2006 70, 1742-1749DOI: (10.1038/sj.ki.5001893) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 6 Renal function and HO-1 mRNA expression in animals treated with SnPPIX before IRI. (a) Mean serum creatinine (s.d.) levels of animals subjected or not to IRI, pre-treated with rapamycin, SnPPIX, both drugs or not (N=5–12). SnPPIX significantly increased renal dysfunction in animals just subjected to IRI (*vs IRI, P=0.011), and in those pre-treated with rapamycin (**vs IRI, P<0.01). (b) SnPPIX treatment repressed HO-1 mRNA expression after IRI (*vs IRI, P<0.01), even in those animals co-treated with rapamycin (N=7) (**vs rapamycin-treated animals subjected to IRI, P<0.01). Kidney International 2006 70, 1742-1749DOI: (10.1038/sj.ki.5001893) Copyright © 2006 International Society of Nephrology Terms and Conditions